Ftse Mib
33.242,20
0,04%
DAX
19.093,18
0,48%
S&P 500
5.917,11
0,00%
NASDAQ
18.966,14
0,00%
Bitcoin
97.606,43
3,44%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrati per grafici in tempo reale, strumenti di analisi e prezzi.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aclarion Inc (ACON) Aclarion Inc (ACON) Notizie

Aclarion Inc

ACON
0,184
0,0076 (4,31%)
Pre Mercato
Ultimo aggiornamento: 14:36:24
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
21/11/202414:00GLOBEAclarion Announces Nociscan Featured in RSNA Edition of..
10/10/202413:00GLOBEAclarion to Participate in the 2024 Maxim Healthcare Virtual..
27/9/202412:57GLOBEAclarion's Nociscan AI Plays Key Role in Advanced..
13/9/202414:30GLOBEPRISM MarketView Showcases Aclarion: Disrupting Chronic Pain..
12/9/202412:57GLOBEAclarion Provides Corporate Update on Nociscan AI Technology..
10/9/202412:57GLOBEAclarion Announces Completion of First Nociscan Exams in..
06/9/202417:27GLOBEAclarion Added to PRISM Emerging Medical Devices Index
05/9/202412:57GLOBEAclarion Launches Surgeon Partnership to Apply Nociscan’s AI..
29/8/202422:01EDGAR2Form 8-K - Current report
29/8/202412:57GLOBEAclarion Launches Second Clinical Utility and Economic..
26/8/202422:02EDGAR2Form DEF 14A - Other definitive proxy statements
23/8/202422:58EDGAR2Form 8-K - Current report
21/8/202413:57GLOBEAclarion Launches the Clinical Utility and Economic (CLUE)..
16/8/202422:56EDGAR2Form 8-K - Current report
16/8/202422:01EDGAR2Form PRE 14A - Other preliminary proxy statements
15/8/202415:48GLOBEAclarion to Present at August 20th Virtual Investor Summit..
14/8/202421:34EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202414:08GLOBEAclarion Announces First Commercial Agreement in Michigan
13/8/202415:07GLOBEAclarion Hits Another Key Milestone by Adding Vitality -..
13/8/202415:05EDGAR2Form 253G3 -
13/8/202413:56EDGAR2Form 8-K/A - Current report: [Amend]
12/8/202422:02EDGAR2Form 8-K - Current report
09/7/202413:00GLOBEAclarion Achieves Milestone With Key Second Payer Coverage..
26/6/202414:30GLOBEAclarion Announces Initial Payer Coverage of Nociscan by AXA..
25/6/202414:30GLOBEAclarion Expands Commercial Engagement With The London..
25/4/202415:14GLOBEAclarion’s Nociscan Solution to Play Key Role in..
06/3/202422:09EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/3/202414:00GLOBEAclarion Announces Publication of Compelling Peer-Reviewed..
27/2/202421:22GLOBEAclarion Announces Closing of $3.0 Million Public Offering
27/2/202420:00EDGAR2Form 8-K - Current report
27/2/202416:46EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
27/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
26/2/202415:15GLOBEAclarion Announces Pricing of $3.0 Million Public Offering
23/2/202417:46EDGAR2Form S-1/A - General form for registration of securities..
21/2/202423:25EDGAR2Form 8-K - Current report
21/2/202421:02EDGAR2Form S-1/A - General form for registration of securities..
06/2/202423:32EDGAR2Form S-1/A - General form for registration of securities..
05/2/202414:00GLOBEAclarion Announces Successful Financings; Plans to Launch..
01/2/202423:16EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
31/1/202423:26EDGAR2Form S-1/A - General form for registration of securities..
29/1/202412:04EDGAR2Form 8-K - Current report
23/1/202415:53EDGAR2Form 8-K - Current report
22/1/202422:48EDGAR2Form S-1 - General form for registration of securities under..
22/1/202414:00GLOBEAclarion Expands Nociscan Access Into Phoenix With Key..
17/1/202414:00GLOBEAclarion Announces Updated Product Release That Expands MRI..
12/1/202422:15EDGAR2Form SC 13G - Statement of acquisition of beneficial..
08/1/202414:00GLOBEAclarion and ATEC Execute Strategic Partnership Agreement to..
04/1/202414:01EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/1/202414:00EDGAR2Form 8-K - Current report
02/1/202418:00GLOBEAclarion Announces Reverse Stock Split
Apertura: Min: Max:
Chiusura: 0,1764

La tua Cronologia

NASDAQ
ACON
Aclarion
LSE
0IR4
Auga Group Ab
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network